This page contains brief information about abemaciclib and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.
Use in Cancer
Abemaciclib is approved to treat:
- Breast cancer that is hormone receptor positive (HR+) and HER2 negative (HER2-) and is advanced or has metastasized (spread to other parts of the body).
- It is used with fulvestrant in women whose disease got worse after treatment with hormone therapy.
- It is used alone in women and men whose disease got worse after treatment with hormone therapy and previous chemotherapy given for metastatic disease.
- It is used with an aromatase inhibitor given as first-line hormone therapy in postmenopausal women.
Abemaciclib is also being studied in the treatment of other types of cancer.
More About Abemaciclib
Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.
Research Results and Related Resources
Clinical Trials Accepting Patients
Find Clinical Trials for Abemaciclib - Check for trials from NCI's list of cancer clinical trials now accepting patients.